{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:35:32Z","timestamp":1793500532639,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jinf.2025.106588","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T15:36:17Z","timestamp":1755012977000},"page":"106588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Neutralizing GM-CSF autoantibodies impair neutrophil antifungal effector function in a patient with aspergillosis"],"prefix":"10.1016","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2531-6349","authenticated-orcid":false,"given":"Andrew L.","family":"Wishart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7869-3634","authenticated-orcid":false,"given":"Joseph","family":"Pechacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey B.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8823-0796","authenticated-orcid":false,"given":"Jigar V.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa A.","family":"Zarakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taura","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Seyedmousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias M.","family":"Hohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9971-0760","authenticated-orcid":false,"given":"Douglas B.","family":"Kuhns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4994-9500","authenticated-orcid":false,"given":"Michail S.","family":"Lionakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jinf.2025.106588_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00140-18","article-title":"Aspergillus fumigatus and Aspergillosis in 2019","volume":"33","author":"Latge","year":"2019","journal-title":"Clin Microbiol Rev"},{"issue":"165","key":"10.1016\/j.jinf.2025.106588_bib2","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med"},{"issue":"7","key":"10.1016\/j.jinf.2025.106588_bib3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41577-022-00826-w","article-title":"Immune responses to human fungal pathogens and therapeutic prospects","volume":"23","author":"Lionakis","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.jinf.2025.106588_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40588-018-0098-6","article-title":"The role of neutrophils in host defense against invasive fungal infections","volume":"5","author":"Desai","year":"2018","journal-title":"Curr Clin Microbiol Rep"},{"key":"10.1016\/j.jinf.2025.106588_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101728","article-title":"Immunity to fungi in the lung","volume":"66","author":"Heung","year":"2023","journal-title":"Semin Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2025.106588_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/imr.12447","article-title":"Priming of the neutrophil respiratory burst: role in host defense and inflammation","volume":"273","author":"El-Benna","year":"2016","journal-title":"Immunol Rev"},{"issue":"12","key":"10.1016\/j.jinf.2025.106588_bib7","doi-asserted-by":"crossref","first-page":"e176142","DOI":"10.1172\/JCI176142","article-title":"BTK drives neutrophil activation for sterilizing antifungal immunity","volume":"134","author":"Desai","year":"2024","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.jinf.2025.106588_bib8","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/infdis\/jiw054","article-title":"Role of granulocyte-macrophage colony-stimulating factor signaling in regulating neutrophil antifungal activity and the oxidative burst during respiratory fungal challenge","volume":"213","author":"Kasahara","year":"2016","journal-title":"J Infect Dis"},{"issue":"105","key":"10.1016\/j.jinf.2025.106588_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adr0547","article-title":"GM-CSF-mediated epithelial-immune cell cross-talk orchestrates pulmonary immunity to Aspergillus fumigatus","volume":"10","author":"Mills","year":"2025","journal-title":"Sci Immunol"},{"issue":"34","key":"10.1016\/j.jinf.2025.106588_bib10","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.2014.60.5121","article-title":"Effect of granulocyte-macrophage colony-stimulating factor on prevention and treatment of invasive fungal disease in recipients of allogeneic stem-cell transplantation: a prospective multicenter randomized phase IV trial","volume":"33","author":"Wan","year":"2015","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jinf.2025.106588_bib11","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.4049\/jimmunol.1202526","article-title":"Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis","volume":"190","author":"Rosen","year":"2013","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2025.106588_bib12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12931-022-02103-9","article-title":"Neutralizing GM-CSF autoantibodies in pulmonary alveolar proteinosis, cryptococcal meningitis and severe nocardiosis","volume":"23","author":"Salvator","year":"2022","journal-title":"Respir Res"},{"issue":"3","key":"10.1016\/j.jinf.2025.106588_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41577-023-00933-2","article-title":"Anti-cytokine autoantibodies: mechanistic insights and disease associations","volume":"24","author":"Cheng","year":"2024","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.jinf.2025.106588_bib14","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/cid\/ciu968","article-title":"Nocardia-induced granulocyte macrophage colony-stimulating factor is neutralized by autoantibodies in disseminated\/extrapulmonary nocardiosis","volume":"60","author":"Rosen","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2025.106588_bib15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.chom.2020.07.019","article-title":"Legionella-infected macrophages engage the alveolar epithelium to metabolically reprogram myeloid cells and promote antibacterial inflammation","volume":"28","author":"Liu","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"12","key":"10.1016\/j.jinf.2025.106588_bib16","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1002\/eji.201242683","article-title":"Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humans","volume":"42","author":"von Bernuth","year":"2012","journal-title":"Eur J Immunol"},{"issue":"7","key":"10.1016\/j.jinf.2025.106588_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004912","article-title":"Deploying FLAREs to visualize functional outcomes of host-pathogen encounters","volume":"11","author":"Heung","year":"2015","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.jinf.2025.106588_bib18","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.celrep.2012.10.026","article-title":"Tracing conidial fate and measuring host cell antifungal activity using a reporter of microbial viability in the lung","volume":"2","author":"Jhingran","year":"2012","journal-title":"Cell Rep"},{"issue":"8","key":"10.1016\/j.jinf.2025.106588_bib19","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.4049\/jimmunol.158.8.3959","article-title":"Endotoxin and IL-1 hyporesponsiveness in a patient with recurrent bacterial infections","volume":"158","author":"Kuhns","year":"1997","journal-title":"J Immunol"},{"issue":"5889","key":"10.1016\/j.jinf.2025.106588_bib20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1126\/science.1158298","article-title":"Pyogenic bacterial infections in humans with MyD88 deficiency","volume":"321","author":"von Bernuth","year":"2008","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jinf.2025.106588_bib21","doi-asserted-by":"crossref","first-page":"e00912","DOI":"10.1128\/mBio.00912-14","article-title":"Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients","volume":"5","author":"Saijo","year":"2014","journal-title":"mBio"},{"issue":"11","key":"10.1016\/j.jinf.2025.106588_bib22","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/imj.14637","article-title":"The significance of anti-granulocyte-macrophage colony-stimulating factor antibodies in cryptococcal infection: case series and review of antibody testing","volume":"49","author":"Stevenson","year":"2019","journal-title":"Intern Med J"},{"issue":"7","key":"10.1016\/j.jinf.2025.106588_bib23","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1164\/rccm.200708-1271OC","article-title":"Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan","volume":"177","author":"Inoue","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jinf.2025.106588_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02733-18","article-title":"Cryptococcus deuterogattii VGIIa infection associated with travel to the Pacific Northwest Outbreak Region in an anti-granulocyte-macrophage colony-stimulating factor autoantibody-positive patient in the United States","volume":"10","author":"Applen Clancey","year":"2019","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.jinf.2025.106588_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx211","article-title":"Autoantibodies to granulocyte-macrophage colony-stimulating factor associated with severe and unusual manifestations of Cryptococcus gattii infections","volume":"4","author":"Crum-Cianflone","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2025.106588_bib26","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s10875-023-01451-5","article-title":"Anti-GM-CSF neutralizing autoantibodies in Colombian patients with disseminated cryptococcosis","volume":"43","author":"Arango-Franco","year":"2023","journal-title":"J Clin Immunol"},{"issue":"7","key":"10.1016\/j.jinf.2025.106588_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10875-024-01757-y","article-title":"Autoantibodies neutralizing GM-CSF in HIV-negative Colombian patients infected with Cryptococcus gattii and C. neoformans","volume":"44","author":"Arango-Franco","year":"2024","journal-title":"J Clin Immunol"},{"issue":"5","key":"10.1016\/j.jinf.2025.106588_bib28","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10875-020-00796-5","article-title":"Anti-GM-CSF autoantibodies and Cryptococcus neoformans var. grubii CNS Vasculitis","volume":"40","author":"Perrineau","year":"2020","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.jinf.2025.106588_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx082","article-title":"Susceptibility to cryptococcal meningoencephalitis associated with idiopathic CD4(+) lymphopenia and secondary germline or acquired defects","volume":"4","author":"Panackal","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2025.106588_bib30","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s10875-022-01341-2","article-title":"Cryptococcus gattii infection as the major clinical manifestation in patients with autoantibodies against granulocyte-macrophage colony-stimulating factor","volume":"42","author":"Wang","year":"2022","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.jinf.2025.106588_bib31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/cid\/ciab920","article-title":"Neutralizing anti-granulocyte-macrophage colony-stimulating factor autoantibodies in patients with central nervous system and localized cryptococcosis: longitudinal follow-up and literature review","volume":"75","author":"Kuo","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2025.106588_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10875-016-0364-4","article-title":"Disseminated cryptococcosis due to anti-granulocyte-macrophage colony-stimulating factor autoantibodies in the absence of pulmonary alveolar proteinosis","volume":"37","author":"Kuo","year":"2017","journal-title":"J Clin Immunol"},{"issue":"6","key":"10.1016\/j.jinf.2025.106588_bib33","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/myc.13247","article-title":"Disseminated cryptococcosis and anti-granulocyte-macrophage colony-stimulating factor autoantibodies: an underappreciated association","volume":"64","author":"Viola","year":"2021","journal-title":"Mycoses"},{"issue":"5","key":"10.1016\/j.jinf.2025.106588_bib34","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.cmi.2024.01.018","article-title":"Anti-GM-CSF autoantibodies predict outcome of cryptococcal meningitis in patients not infected with HIV: a cohort study","volume":"30","author":"Jiang","year":"2024","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.jinf.2025.106588_bib35","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1186\/s12879-024-10267-6","article-title":"Disseminated Cryptococcal Gattii infection in a patient with anti-granulocyte-macrophage colony-stimulating-factor autoantibody: a case report","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2025.106588_bib36","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1111\/1346-8138.17174","article-title":"Antigranulocyte macrophage colony stimulating factor autoantibodies:\u00a0the underlying cause in seemingly immunocompetent patients with disseminated cryptococcosis","volume":"51","author":"Fang","year":"2024","journal-title":"J Dermatol"},{"key":"10.1016\/j.jinf.2025.106588_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-222940","article-title":"Pulmonary alveolar proteinosis following cryptococcal meningitis: a possible cause?","volume":"2018","author":"Demir","year":"2018","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1016\/j.jinf.2025.106588_bib38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jinf.2012.03.020","article-title":"Opportunistic infections in patients with pulmonary alveolar proteinosis","volume":"65","author":"Punatar","year":"2012","journal-title":"J Infect"},{"issue":"24","key":"10.1016\/j.jinf.2025.106588_bib39","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.2169\/internalmedicine.54.5034","article-title":"Autoimmune pulmonary alveolar proteinosis following pulmonary aspergillosis","volume":"54","author":"Arai","year":"2015","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.jinf.2025.106588_bib40","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1086\/368383","article-title":"Regulation by granulocyte-macrophage colony-stimulating factor and\/or steroids given in vivo of proinflammatory cytokine and chemokine production by bronchoalveolar macrophages in response to Aspergillus conidia","volume":"187","author":"Brummer","year":"2003","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2025.106588_bib41","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/infdis\/170.4.894","article-title":"Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-gamma","volume":"170","author":"Roilides","year":"1994","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2025.106588_bib42","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1093\/cid\/ciy473","article-title":"Breakthrough invasive mold infections in the hematology patient: current concepts and future directions","volume":"67","author":"Lionakis","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2025.106588_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01230-18","article-title":"In vitro activity of isavuconazole against opportunistic fungal pathogens from two mycology reference laboratories","volume":"62","author":"Pfaller","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.jinf.2025.106588_bib44","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/cid\/ciaa1086","article-title":"Daratumumab (Anti-CD38) for treatment of disseminated nontuberculous mycobacteria in a patient with anti-interferon-gamma autoantibodies","volume":"72","author":"Ochoa","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"17","key":"10.1016\/j.jinf.2025.106588_bib45","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1182\/blood-2011-12-395707","article-title":"Anti-CD20 (rituximab) therapy for anti-IFN-gamma autoantibody-associated nontuberculous mycobacterial infection","volume":"119","author":"Browne","year":"2012","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.jinf.2025.106588_bib46","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1056\/NEJMoa2312665","article-title":"The role of interferon-gamma in autoimmune polyendocrine syndrome type 1","volume":"390","author":"Oikonomou","year":"2024","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jinf.2025.106588_bib47","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jaci.2022.06.009","article-title":"Clinical exome sequencing of 1000 families with complex immune phenotypes: towards comprehensive genomic evaluations","volume":"150","author":"Similuk","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"322","key":"10.1016\/j.jinf.2025.106588_bib48","doi-asserted-by":"crossref","first-page":"322ra10","DOI":"10.1126\/scitranslmed.aac7718","article-title":"CXCR1-mediated neutrophil degranulation and fungal killing promote Candida clearance and host survival","volume":"8","author":"Swamydas","year":"2016","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.jinf.2025.106588_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005293","article-title":"CARD9-dependent neutrophil recruitment protects against fungal invasion of the central nervous system","volume":"11","author":"Drummond","year":"2015","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.jinf.2025.106588_bib50","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1086\/515670","article-title":"Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-gamma receptor 1 deficiency","volume":"178","author":"Holland","year":"1998","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2025.106588_bib51","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s10875-011-9621-8","article-title":"Determination of human anticytokine autoantibody profiles using a particle-based approach","volume":"32","author":"Ding","year":"2012","journal-title":"J Clin Immunol"},{"issue":"7071","key":"10.1016\/j.jinf.2025.106588_bib52","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nature04332","article-title":"Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus","volume":"438","author":"Nierman","year":"2005","journal-title":"Nature"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325001884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325001884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:12:36Z","timestamp":1772802756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445325001884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0163445325001884"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106588","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutralizing GM-CSF autoantibodies impair neutrophil antifungal effector function in a patient with aspergillosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106588","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106588"}}